Objective
To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and AIM/NEX quoted UK companies which meet the relevant criteria under the VCT Rules.
AIC sector
Management group
Seneca Partners Limited
Launch date
07/09/2018
Domicile
United Kingdom
Fund manager
John Davies, Connor Grimes, Matt Currie
Dividend frequency
Semi-Annually
Wind-up provisions
The Directors are required by the articles of the association to propose an ordinary resolution at the Company's AGM in 2024 that the Company should continue as a VCT for a further three year period, and at three yearly intervals thereafter. If any such resolution is not passed, the Directors shall within four months convene a general meeting to consider the proposals for the reorganisation or winding up of the Company.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
13.18 15.59 60.50 71.60 -15.50 N/A 4.96 Apr, Dec 2.99 (31/12/2023)
Scroll

Note

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
02/05/2024 17/05/2024 1.500 No 2024
07/12/2023 22/12/2023 1.500 No 2023
04/05/2023 19/05/2023 1.500 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
Seneca Growth Capital VCT B shares Share price total return -9.8 -29.3 -27.4 N/A
VCT Generalist AIC sector Share price total return -1.1 5.9 24.3 91.2
Scroll

Share structure

Number of shares
21,780,329

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 0 0 131,421 159,214
Average N/A N/A 502 122
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total N/A N/A 0.09 0.12
Average N/A 0.00 0.00 0.00
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BG13MH08 SVCT GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 30/06/2022

Investment % of total assets
Solascure Limited 14.1
ProBiotix Health Plc 10.2
Polarean Imaging Plc 9.4
Arecor Therapeutics Plc 7.8
Fabacus Holdings Limited 7.3
Old St Labs Limited 6.5
Silkfred Limited 6.5
Qudini Limited 6.5
Aptamer Group Plc 5.9
Poolbeg Pharma Plc 5.0

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.